Based on the findings of the current systematic review and meta-analysis, it is apparent that elevated levels of TGF-β expression may serve as a substantial prognostic indicator for patients diagnosed with bladder cancer. The gene discussed is TGFB1; the disease is urinary bladder carcinoma.